Besides anticancer treatment, HDACi is also explored with the suitable therapeutic candidates including rosiglitazone, metformin for the treatment of Alzheimer's disease (AD) implicated by brain insulin signal anomalies. The gene discussed is INS; the disease is Alzheimer disease.